The Nicotine Replacement Therapy Market size was valued at USD 3.13 Billion in 2023 and is expected to reach USD 4.49 Billion By 2031 and grow at a CAGR of 4.61% over the forecast period of 2024-2031.
The nicotine Replacement Therapy (NRT) market refers to the industry that focuses on delivering products aimed at helping individuals stop or lessen their tobacco or nicotine addiction. NRT is using different products that supply nicotine to the body at regulated levels without the hazardous chemicals in tobacco smoke. These drugs are commonly used to help roll back symptoms & cravings associated with resigning smoking. Common types of NRT include nicotine patches, gum, lozenges, inhalers, nasal sprays, and sublingual tablets. These products are available over-the-counter (OTC) in many countries, although others may require a prescription in some places. The NRT industry has undergone substantial growth over the years as more individuals seek effective ways to stop smoking or move to healthier alternatives.
The market is driven by factors such as increasing awareness about the harmful consequences of smoking, rising government measures to support smoking cessation programs and a growing need for safe nicotine delivery systems. The market consists of pharmaceutical corporations and manufacturers who make and distribute NRT products. Companies in this sector invest in research and development to improve existing products, increase efficacy, and develop new formulations. They also participate in marketing and educational activities to create awareness about the benefits of NRT and to urge smokers to stop smoking. According to WHO, 1.92 million people worldwide will die from tobacco-related cardiovascular disease every year. Tobacco smoking accelerates the build-up of plaque, which can result in an increase in heart rate, blood flow to the heart, blood pressure, and narrowing of the arteries. As a result of the negative health consequences of smoking, many countries have implemented strict laws, such as bans on nicotine items such as gutka, and higher taxation on tobacco products such as cigarettes, and cigars.
An increase in the number of hospitals, an increase in access to healthcare facilities across the globe, and an improvement in healthcare expenditure have led to market growth. There has been an increase in government efforts to provide better healthcare facilities. Furthermore, growth in private hospital divisions, ambulatory surgical clinics, and medical tourism fuel the rise of the nicotine replacement therapy industry.
Improving knowledge of the harmful consequences of smoking and the benefits of quitting has increased the demand for smoking cessation tools such as NRTs.
When humans take nicotine inside the body through smoking, the human body becomes addicted to nicotine and nicotine affects the brain, causing it to seek nicotine.
You have to suffer from cigarette withdrawal symptoms when you try to quit smoking. You start feeling nervous and anxious and your body starts craving for nicotine intensely. As a result of these symptoms, most people turn to one cigarette at a time and are unable to quit.
Restrain
NRT treatments have usefulness in helping patients manage withdrawal symptoms and cravings. their success rates in achieving long-term smoking cessation might vary.
The availability of nicotine replacement therapy products and their Accessibility.
NRT products are typically accessible over-the-counter, their accessibility might differ among locations. In certain countries, various kinds of NRT may require a prescription, which might present difficulties for people seeking these drugs. Moreover, in disadvantaged areas or low-income neighbourhoods, the availability and price of NRT may be limited, making it less accessible to individuals who need it.
Opportunity
Governments, public health groups, and healthcare practitioners throughout the world are intensifying their efforts to prevent smoking and minimize tobacco-related damage.
Collaborating with local healthcare providers and organizations can also aid in market penetration.
As the smoking rates in emerging countries and the knowledge about health problems related to smoking are on the rise, there is significant potential in the market for NRT treatments. Companies can enter new markets by adapting their goods, marketing techniques, and pricing to meet local needs. Further collaboration with the local market can also go a long way in expanding the market
Challenge
NRT drugs can help patients manage withdrawal symptoms and cravings, the long-term success rates in attaining total smoking cessation might be low.
Competition from Alternative Products in the local and international markets.
The NRT market faces competition from several alternative medicines and procedures used for smoking cessation. This includes prescription drugs like varenicline or bupropion and new alternatives like e-cigarettes or vaping devices. These alternatives may provide different modes of action, convenience, or perceived efficacy and might pose challenges to the acceptance and market share of standard NRT solutions.
Due to the Russia-Ukraine Conflict there are negative impacts worldwide, especially across Eastern & Central Asia, European Union, the United States, and Eastern Europe. This issue has severely dominated people's lives & livelihoods or represents far-reaching dismission in trade dynamics. The potential impact of ongoing war & uncertainty in Eastern Europe is required to have an aversive impact on Ukraine or long-term effects on Russia. The account uncovers the implications in order to demand-supply equilibration, pressure on the determination of price variants, effect on import/export & trading, or short-term recommendations to the omnibus Nicotine Replacement Therapy Market considering the present update on the conflict & its catholic responses.
A study from Russia states that the effect of e-cigarette products is increasing year by year. In reports, simulation research yields favourable results in 88.2% of e-cigarette situations, with life-years saved ranging from 3.4 million to 38.7 million. In comparison, the estimated life-years saved by vaping range from 1.8 to 18.8% of the expected life-years lost by smoking. So, Russia is a great market as well as a challenging market for nicotine replacement therapy, because of the high number of people who use nicotine.
Impact of Ongoing Recession
Globally, prices have increased significantly in the last two years as a result of increased inflation in developed economies. Cumulatively declining gross purchasing power is expected to have a significant impact on developing economies and is believed to be helpful in several ways. Universal economics highlights the impact of increased inflation on long-term performance and provides scope for fiscal policies to measure and mitigate its short-term impact on currency exchange, cash flows and demand/supply. Nicotine replacement therapy is a high-cost therapy. If the inflation rate is high then the common people cannot buy the product/service. This also affects the new research and development in the company. Because if the common people do not have money, they will neither buy the product nor will the company benefit from it.
by Product
Gums
Patches
Lozenges
Others
by Sales Channel
Offline
Online
by Location
Deaddiction centres and Hospitals
Home
.png)
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
North America & Europe: North America and Europe account for approximately 80-82% of the nicotine replacement treatment market. In 2020, the North American market was worth USD 1.34 billion. The dominance of this area can be attributed to the greatest retail sales of NRT goods in the United States and Canada. The number of smokers following the smoking ban is rising in the region, raising demand for various items such as gum, inhalers, etc. Even, smoking cessation rates in America are elevated than in further nations, resulting in improved sales of these products. According to a poll conducted by the Centres for Disease Control and Prevention (CDC), around 69-70% of the U.S. population has opted to stop smoking. As a result, goods sales are expected to increase in the next few years. Furthermore, gum is more commonly used in the United States to quit smoking than other treatments on the market.
Asia-Pacific: The Asia-Pacific area has a high smoking population and has tremendous potential for the NRT industry. Countries like China and India have big cigarette markets and high smoking rates, giving them a potential client base for NRT products. Australia and New Zealand have well-established NRT markets, with extensive smoking cessation programs, strict regulations, and the availability of subsidized NRT through healthcare systems. Due to intensifying rivalry among the area's major tobacco firms, Asia-Pacific is predicted to be the fastest-growing region over the forecast period of 2022-2030. Furthermore, the expansion of healthcare infrastructure and increased demand for NRT products would accelerate the market's growth rate in this area.
The major key players are Lucy Goods Inc, Pfizer Inc, GlaxoSmithKline plc, Cipla Ltd, PL Developments, Rubicon Research Pvt Ltd, Sparsha Pharma International Pvt. Ltd. Johnson & Johnson Inc, Zydus Cadila, Fertin Pharma Limited and others.
Dr. Reddy's: In 2022, Dr. Reddy introduced Nicotine Polacrilex Lozenges (Nicorette) in the American market.
JB Chemicals: In 2021, JB Chemicals introduced the 'NOSMOK' brand of medicated nicotine lozenges.
Nicorette: In 2019, Nicorette launched new nicotine lozenges in an attempt to entice customers away from vaping.
| Report Attributes | Details |
| Market Size in 2023 | US$ 3.13 Bn |
| Market Size by 2031 | US$ 4.49 Bn |
| CAGR | CAGR of 4.61% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Gums, Patches, Lozenges, Others) • By Sales Channel (Offline, Online) • By Location (Deaddiction centres and Hospitals, Home) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa]), Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Lucy Goods Inc, Pfizer Inc, GlaxoSmithKline plc, Cipla Ltd, PL Developments, Rubicon Research Pvt Ltd, Sparsha Pharma International Pvt. Ltd. Johnson & Johnson Inc, Zydus Cadila, Fertin Pharma Limited and others |
| Key Drivers | • Improving knowledge of the harmful consequences of smoking and the benefits of quitting has increased the demand for smoking cessation tools such as NRTs. • When humans take nicotine inside the body through smoking, the human body becomes addicted to nicotine and nicotine affects the brain, causing it to seek nicotine. |
| Market Opportunities | • Governments, public health groups, and healthcare practitioners throughout the world are intensifying their efforts to prevent smoking and minimize tobacco-related damage. • Collaborating with local healthcare providers and organizations can also aid in market penetration. |
Ans: The Nicotine Replacement Therapy Market size is expected to grow at a CAGR of 4.5% over the forecast period of 2023-2030.
Ans: The Nicotine Replacement Therapy Market size was USD 3.0 billion in 2022 and is expected to Reach USD 4.26 billion by 2030.
Ans: Furthermore, adverse effects associated with nicotine replacement treatment, such as headaches, nausea, and other digestive issues, will serve as a restraint and further limit market expansion throughout the forecast period.
Ans: Factors such as an increase in the prevalence of tobacco-related diseases such as cancer and heart disease, advancements in nicotine replacement therapy, and an increase in population awareness about the negative effects of tobacco on health drive the growth of the nicotine replacement therapy market.
Ans: The largest geographical market for Nicotine Replacement Therapy is North America.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine-Russia War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Nicotine Replacement Therapy Market Segmentation, by Product
8.1 Gums
8.2 Patches
8.3 Lozenges
8.4 Others
9. Nicotine Replacement Therapy Market Segmentation, by Sales Channel
9.1 Offline
9.2 Online
10. Nicotine Replacement Therapy Market Segmentation, by Location
10.1 Deaddiction centres and Hospitals
10.2 Home
11.1 Introduction
11.2 North America
11.2.1 North America Nicotine Replacement Therapy Market by Country
11.2.2 North America Nicotine Replacement Therapy Market by Product
11.2.3 North America Nicotine Replacement Therapy Market by Sales Channel
11.2.4 North America Nicotine Replacement Therapy Market by Location
11.2.5 USA
11.2.5.1 USA Nicotine Replacement Therapy Market by Product
11.2.5.2 USA Nicotine Replacement Therapy Market by Sales Channel
11.2.5.3 USA Nicotine Replacement Therapy Market by Location
11.2.6 Canada
11.2.6.1 Canada Nicotine Replacement Therapy Market by Product
11.2.6.2 Canada Nicotine Replacement Therapy Market by Sales Channel
11.2.6.3 Canada Nicotine Replacement Therapy Market by Location
11.2.7 Mexico
11.2.7.1 Mexico Nicotine Replacement Therapy Market by Product
11.2.7.2 Mexico Nicotine Replacement Therapy Market by Sales Channel
11.2.7.3 Mexico Nicotine Replacement Therapy Market by Location
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Nicotine Replacement Therapy Market by country
11.3.1.2 Eastern Europe Nicotine Replacement Therapy Market by Product
11.3.1.3 Eastern Europe Nicotine Replacement Therapy Market by Sales Channel
11.3.1.4 Eastern Europe Nicotine Replacement Therapy Market by Location
11.3.1.5 Poland
11.3.1.5.1 Poland Nicotine Replacement Therapy Market by Product
11.3.1.5.2 Poland Nicotine Replacement Therapy Market by Sales Channel
11.3.1.5.3 Poland Nicotine Replacement Therapy Market by Location
11.3.1.6 Romania
11.3.1.6.1 Romania Nicotine Replacement Therapy Market by Product
11.3.1.6.2 Romania Nicotine Replacement Therapy Market by Sales Channel
11.3.1.6.4 Romania Nicotine Replacement Therapy Market by Location
11.3.1.7 Turkey
11.3.1.7.1 Turkey Nicotine Replacement Therapy Market by Product
11.3.1.7.2 Turkey Nicotine Replacement Therapy Market by Sales Channel
11.3.1.7.3 Turkey Nicotine Replacement Therapy Market by Location
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Nicotine Replacement Therapy Market by Product
11.3.1.8.2 Rest of Eastern Europe Nicotine Replacement Therapy Market by Sales Channel
11.3.1.8.3 Rest of Eastern Europe Nicotine Replacement Therapy Market by Location
11.3.2 Western Europe
11.3.2.1 Western Europe Nicotine Replacement Therapy Market by country
11.3.2.2 Western Europe Nicotine Replacement Therapy Market by Product
11.3.2.3 Western Europe Nicotine Replacement Therapy Market by Sales Channel
11.3.2.4 Western Europe Nicotine Replacement Therapy Market by Location
11.3.2.5 Germany
11.3.2.5.1 Germany Nicotine Replacement Therapy Market by Product
11.3.2.5.2 Germany Nicotine Replacement Therapy Market by Sales Channel
11.3.2.5.3 Germany Nicotine Replacement Therapy Market by Location
11.3.2.6 France
11.3.2.6.1 France Nicotine Replacement Therapy Market by Product
11.3.2.6.2 France Nicotine Replacement Therapy Market by Sales Channel
11.3.2.6.3 France Nicotine Replacement Therapy Market by Location
11.3.2.7 UK
11.3.2.7.1 UK Nicotine Replacement Therapy Market by Product
11.3.2.7.2 UK Nicotine Replacement Therapy Market by Sales Channel
11.3.2.7.3 UK Nicotine Replacement Therapy Market by Location
11.3.2.8 Italy
11.3.2.8.1 Italy Nicotine Replacement Therapy Market by Product
11.3.2.8.2 Italy Nicotine Replacement Therapy Market by Sales Channel
11.3.2.8.3 Italy Nicotine Replacement Therapy Market by Location
11.3.2.9 Spain
11.3.2.9.1 Spain Nicotine Replacement Therapy Market by Product
11.3.2.9.2 Spain Nicotine Replacement Therapy Market by Sales Channel
11.3.2.9.3 Spain Nicotine Replacement Therapy Market by Location
11.3.2.10 Netherlands
11.3.2.10.1 Netherlands Nicotine Replacement Therapy Market by Product
11.3.2.10.2 Netherlands Nicotine Replacement Therapy Market by Sales Channel
11.3.2.10.3 Netherlands Nicotine Replacement Therapy Market by Location
11.3.2.11 Switzerland
11.3.2.11.1 Switzerland Nicotine Replacement Therapy Market by Product
11.3.2.11.2 Switzerland Nicotine Replacement Therapy Market by Sales Channel
11.3.2.11.3 Switzerland Nicotine Replacement Therapy Market by Location
11.3.2.1.12 Austria
11.3.2.12.1 Austria Nicotine Replacement Therapy Market by Product
11.3.2.12.2 Austria Nicotine Replacement Therapy Market by Sales Channel
11.3.2.12.3 Austria Nicotine Replacement Therapy Market by Location
11.3.2.13 Rest of Western Europe
11.3.2.13.1 Rest of Western Europe Nicotine Replacement Therapy Market by Product
11.3.2.13.2 Rest of Western Europe Nicotine Replacement Therapy Market by Sales Channel
11.3.2.13.3 Rest of Western Europe Nicotine Replacement Therapy Market by Location
11.4 Asia-Pacific
11.4.1 Asia-Pacific Nicotine Replacement Therapy Market by country
11.4.2 Asia-Pacific Nicotine Replacement Therapy Market by Product
11.4.3 Asia-Pacific Nicotine Replacement Therapy Market by Sales Channel
11.4.4 Asia-Pacific Nicotine Replacement Therapy Market by Location
11.4.5 China
11.4.5.1 China Nicotine Replacement Therapy Market by Product
11.4.5.2 China Nicotine Replacement Therapy Market by Location
11.4.5.3 China Nicotine Replacement Therapy Market by Sales Channel
11.4.6 India
11.4.6.1 India Nicotine Replacement Therapy Market by Product
11.4.6.2 India Nicotine Replacement Therapy Market by Sales Channel
11.4.6.3 India Nicotine Replacement Therapy Market by Location
11.4.7 Japan
11.4.7.1 Japan Nicotine Replacement Therapy Market by Product
11.4.7.2 Japan Nicotine Replacement Therapy Market by Sales Channel
11.4.7.3 Japan Nicotine Replacement Therapy Market by Location
11.4.8 South Korea
11.4.8.1 South Korea Nicotine Replacement Therapy Market by Product
11.4.8.2 South Korea Nicotine Replacement Therapy Market by Sales Channel
11.4.8.3 South Korea Nicotine Replacement Therapy Market by Location
11.4.9 Vietnam
11.4.9.1 Vietnam Nicotine Replacement Therapy Market by Product
11.4.9.2 Vietnam Nicotine Replacement Therapy Market by Sales Channel
11.4.9.3 Vietnam Nicotine Replacement Therapy Market by Location
11.4.10 Singapore
11.4.10.1 Singapore Nicotine Replacement Therapy Market by Product
11.4.10.2 Singapore Nicotine Replacement Therapy Market by Sales Channel
11.4.10.3 Singapore Nicotine Replacement Therapy Market by Location
11.4.11 Australia
11.4.11.1 Australia Nicotine Replacement Therapy Market by Product
11.4.11.2 Australia Nicotine Replacement Therapy Market by Sales Channel
11.4.11.3 Australia Nicotine Replacement Therapy Market by Location
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Nicotine Replacement Therapy Market by Product
11.4.12.2 Rest of Asia-Pacific Nicotine Replacement Therapy Market by Sales Channel
11.4.12.3 Rest of Asia-Pacific Nicotine Replacement Therapy Market by Location
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Nicotine Replacement Therapy Market by country
11.5.1.2 Middle East Nicotine Replacement Therapy Market by Product
11.5.1.3 Middle East Nicotine Replacement Therapy Market by Sales Channel
11.5.1.4 Middle East Nicotine Replacement Therapy Market by Location
11.5.1.5 UAE
11.5.1.5.1 UAE Nicotine Replacement Therapy Market by Product
11.5.1.5.2 UAE Nicotine Replacement Therapy Market by Sales Channel
11.5.1.5.3 UAE Nicotine Replacement Therapy Market by Location
11.5.1.6 Egypt
11.5.1.6.1 Egypt Nicotine Replacement Therapy Market by Product
11.5.1.6.2 Egypt Nicotine Replacement Therapy Market by Sales Channel
11.5.1.6.3 Egypt Nicotine Replacement Therapy Market by Location
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Nicotine Replacement Therapy Market by Product
11.5.1.7.2 Saudi Arabia Nicotine Replacement Therapy Market by Sales Channel
11.5.1.7.3 Saudi Arabia Nicotine Replacement Therapy Market by Location
11.5.1.8 Qatar
11.5.1.8.1 Qatar Nicotine Replacement Therapy Market by Product
11.5.1.8.2 Qatar Nicotine Replacement Therapy Market by Sales Channel
11.5.1.8.3 Qatar Nicotine Replacement Therapy Market by Location
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Nicotine Replacement Therapy Market by Product
11.5.1.9.2 Rest of Middle East Nicotine Replacement Therapy Market by Sales Channel
11.5.1.9.3 Rest of Middle East Nicotine Replacement Therapy Market by Location
11.5.2 Africa
11.5.2.1 Africa Transfusion Diagnostics Market by country
11.5.2.2 Africa Nicotine Replacement Therapy Market by Product
11.5.2.3 Africa Nicotine Replacement Therapy Market by Sales Channel
11.5.2.4 Africa Nicotine Replacement Therapy Market by Location
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Nicotine Replacement Therapy Market by Product
11.5.2.5.2 Nigeria Nicotine Replacement Therapy Market by Sales Channel
11.5.2.5.3 Nigeria Nicotine Replacement Therapy Market by Location
11.5.2.6 South Africa
11.5.2.6.1 South Africa Nicotine Replacement Therapy Market by Product
11.5.2.6.2 South Africa Nicotine Replacement Therapy Market by Sales Channel
11.5.2.6.3 South Africa Nicotine Replacement Therapy Market by Location
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Nicotine Replacement Therapy Market by Product
11.5.2.7.2 Rest of Africa Nicotine Replacement Therapy Market by Sales Channel
11.5.2.7.3 Rest of Africa Nicotine Replacement Therapy Market by Location
11.6 Latin America
11.6.1 Latin America Nicotine Replacement Therapy Market by country
11.6.2 Latin America Nicotine Replacement Therapy Market by Product Type
11.6.3 Latin America Nicotine Replacement Therapy Market by Sales Channel
11.6.4 Latin America Nicotine Replacement Therapy Market by Location
11.6.5 Brazil
11.6.5.1 Brazil America Nicotine Replacement Therapy by Product Type
11.6.5.2 Brazil America Nicotine Replacement Therapy by Sales Channel
11.6.5.3 Brazil America Nicotine Replacement Therapy by Location
11.6.6 Argentina
11.6.6.1 Argentina America Nicotine Replacement Therapy by Product Type
11.6.6.2 Argentina America Nicotine Replacement Therapy by Sales Channel
11.6.6.3 Argentina America Nicotine Replacement Therapy by Location
11.6.7 Colombia
11.6.7.1 Colombia America Nicotine Replacement Therapy by Product Type
11.6.7.2 Colombia America Nicotine Replacement Therapy by Sales Channel
11.6.7.3 Colombia America Nicotine Replacement Therapy by Location
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Nicotine Replacement Therapy by Product Type
11.6.8.2 Rest of Latin America Nicotine Replacement Therapy by Sales Channel
11.6.8.3 Rest of Latin America Nicotine Replacement Therapy by Location
12. Company profile
12.1 Lucy Goods Inc
12.1.1 Market Overview
12.1.2 Financials
12.1.3 Product/Services/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Pfizer Inc
12.2.1 Market Overview
12.2.2 Financials
12.2.3 Product/Services/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 GlaxoSmithKline plc
12.3.1 Market Overview
12.3.2 Financials
12.3.3 Product/Services/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Cipla Ltd
12.4.1 Market Overview
12.4.1 Financials
12.4.3 Product/Services/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 PL Developments
12.5.1 Market Overview
12.5.2 Financials
12.5.3 Product/Services/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Rubicon Research Pvt Ltd
12.6.1 Market Overview
12.6.2 Financials
12.6.3 Product/Services/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Sparsha Pharma International Pvt. Ltd.
12.7.1 Market Overview
12.7.2 Financials
12.7.3 Product/Services/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Johnson & Johnson Inc
12.8.2 Financials
12.8.3 Product/Services/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Zydus Cadila
12.9.1 Market Overview
12.9.2 Financials
12.9.3 Product/Services/Offerings
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Fertin Pharma Limited
12.10.1 Market Overview
12.10.2 Financials
12.10.3 Product/Services/Offerings
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Types
14. Conclusion
15. USE Cases and Best Practices
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Topical Drug Delivery Market Size was valued at USD 225.73 billion in 2022 and is expected to reach USD 449.79 billion by 2030 and grow at a CAGR of 9% over the forecast period 2023-2030.
The Healthcare Supply Chain Management Market is expected to reach USD 10.14 billion by 2031, and Size was valued at USD 3 billion in 2023, and grow at a CAGR of 14.5 % over the forecast period 2024-2031.
The Platelet Rich Plasma Market size was estimated USD 628.1 million in 2022 and is expected to reach USD 1948.2 million by 2030 at a CAGR of 15.2% during the forecast period of 2023-2030.
The Pregnancy Pillow Market was estimated at USD 628.2 million in 2022 and is poised to reach at 805.7million in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 3.16% for the forecast period of 2023-2030.
The Healthcare Quality Management Market Size was valued at USD 3.45 billion in 2022 and is expected to reach USD 10.42 billion by 2030, and grow at a CAGR of 14.8% over the forecast period 2023-2030.
The Cleanroom Technologies Market Size was valued at USD 4.62 billion in 2022 and is expected to reach USD 7.12 billion by 2030 and grow at a CAGR of 5.5% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
